» Articles » PMID: 30360030

Severe Acute Alcoholic Hepatitis and Liver Transplant: A Never-ending Mournful Story

Overview
Specialty Gastroenterology
Date 2018 Oct 26
PMID 30360030
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Severe acute alcoholic liver disease (SAAH) unresponsive to medical therapy shows one-year-mortality rates of up to 90%. Most transplant centers request six months of alcohol abstinence prior to transplantation, the so-called "6-month rule." This regulation is not based on strong evidence, repeatedly making it a topic of controversial debates. The majority of patients with SAAH will die before fulfilling the 6-month rule. Therefore, liver transplantation (LT) protocols are becoming more flexible towards the rigid abstinence regulation, especially concerning SAAH patients. We conducted a literature review regarding LT in SAAH and its outcomes, including post-transplant mortality and recidivism. We studied available data on PubMed from 2011 and onwards whilst including articles dealing with genetic components, medical therapy and historic snapshots of alcoholism. Emerging studies recommend LT in SAAH not responding to medical therapies even without realizing the required abstinence period, since the majority of these patients would die within 6 months. SAAH without response to medical therapy has one-year-mortality rates of up to 90%. The 6-month rule is not based on strong evidence and is repeatedly a topic of controversial debates. There is genetic linkage to alcoholism and medical therapy is not as effective as estimated, yet. The 6-months-regulation has not shown to evidently decrease the risk of recidivism post-LT, which is a lifesaving treatment in SAAH patients. Insisting on rigid sobriety rules results in excluding patients with a low risk of recidivism from being transplanted. Moreover, the genetic linkage of alcoholism must be recognized.

Citing Articles

Outcome of patients with severe alcoholic hepatitis after Model for End-Stage Liver Disease-based allocation system implementation in Korea.

Kwon T, Kang W, Gwak G, Paik Y, Choi M, Lee J Korean J Transplant. 2022; 35(1):24-32.

PMID: 35769621 PMC: 9235328. DOI: 10.4285/kjt.20.0054.


Early Liver Transplantation for Severe Alcoholic Hepatitis.

Mellinger J, Stine J Dig Dis Sci. 2020; 65(6):1608-1614.

PMID: 32107678 PMC: 7230003. DOI: 10.1007/s10620-020-06159-9.


Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope.

Gala K, Vatsalya V Cells. 2020; 9(3).

PMID: 32106390 PMC: 7140524. DOI: 10.3390/cells9030524.

References
1.
Obed A, Stern S, Jarrad A, Lorf T . Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients. World J Gastroenterol. 2015; 21(14):4423-6. PMC: 4394109. DOI: 10.3748/wjg.v21.i14.4423. View

2.
Nguyen-Khac E, Thevenot T, Piquet M, Benferhat S, Goria O, Chatelain D . Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med. 2011; 365(19):1781-9. DOI: 10.1056/NEJMoa1101214. View

3.
Glannon W . Responsibility, alcoholism, and liver transplantation. J Med Philos. 1998; 23(1):31-49. DOI: 10.1076/jmep.23.1.31.2595. View

4.
Wang J, Hinrichs A, Stock H, Budde J, Allen R, Bertelsen S . Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome. Hum Mol Genet. 2004; 13(17):1903-11. DOI: 10.1093/hmg/ddh194. View

5.
Lee B, Terrault N . Early liver transplantation for severe alcoholic hepatitis: moving from controversy to consensus. Curr Opin Organ Transplant. 2018; 23(2):229-236. PMC: 6423506. DOI: 10.1097/MOT.0000000000000507. View